CER - Central Repository
Institute of Chemistry, Technology and Metallurgy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   CER
  • IHTM
  • Radovi istraživača / Researchers' publications
  • View Item
  •   CER
  • IHTM
  • Radovi istraživača / Researchers' publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Inorganically modified diatomite as a potential prolonged-release drug carrier

Authorized Users Only
2014
Authors
Janicijevic, Jelena
Krajisnik, Danina
Calija, Bojan
Dobricic, Vladimir
Dakovic, Aleksandra
Krstić, Jugoslav
Marković, Marija
Milic, Jela
Article (Published version)
Metadata
Show full item record
Abstract
Inorganic modification of diatomite was performed with the precipitation product of partially neutralized aluminum sulfate solution at three different mass ratios. The starting and the modified diatomites were characterized by SEM-EDS, FTIR, thermal analysis and zeta potential measurements and evaluated for drug loading capacity in adsorption batch experiments using diclofenac sodium (DS) as a model drug. In vitro drug release studies were performed in phosphate buffer pH 6.8 from comprimates containing: the drug adsorbed onto the selected modified diatomite sample (DAMD), physical mixture of the drug with the selected modified diatomite sample (PMDMD) and physical mixture of the drug with the starting diatomite (PMDD). In vivo acute toxicity testing of the modified diatomite samples was performed on mice. High adsorbent loading of the selected modified diatomite sample (similar to 250 mg/g in 2 h) enabled the preparation of comprimates containing adsorbed DS in the amount near to its ...therapeutic dose. Drug release studies demonstrated prolonged release of DS over a period of 8 h from both DAMD comprimates (18% after 8 h) and PMDMD comprimates (45% after 8 h). The release kinetics for DAMD and PMDMD comprimates fitted well with Korsmeyer-Peppas and Bhaskar models, indicating that the release mechanism was a combination of non-Fickian diffusion and ion exchange process.

Keywords:
Diatomite / Inorganic modification / Diclofenac sodium / Adsorption / Prolonged drug release
Source:
Materials Science & Engineering C-Materials For Biological Applications, 2014, 42, 412-420
Publisher:
  • Elsevier
Funding / projects:
  • Development of micro- and nanosystems as carriers for drugs with anti-inflammatory effect and methods for their characterization (RS-34031)
  • Oxide-based environmentally-friendly porous materials for genotoxic substances removal (RS-172018)

DOI: 10.1016/j.msec.2014.05.052

ISSN: 0928-4931

PubMed: 25063135

WoS: 000340687400052

Scopus: 2-s2.0-84902655546
[ Google Scholar ]
23
16
URI
https://cer.ihtm.bg.ac.rs/handle/123456789/1589
Collections
  • Radovi istraživača / Researchers' publications
Institution/Community
IHTM
TY  - JOUR
AU  - Janicijevic, Jelena
AU  - Krajisnik, Danina
AU  - Calija, Bojan
AU  - Dobricic, Vladimir
AU  - Dakovic, Aleksandra
AU  - Krstić, Jugoslav
AU  - Marković, Marija
AU  - Milic, Jela
PY  - 2014
UR  - https://cer.ihtm.bg.ac.rs/handle/123456789/1589
AB  - Inorganic modification of diatomite was performed with the precipitation product of partially neutralized aluminum sulfate solution at three different mass ratios. The starting and the modified diatomites were characterized by SEM-EDS, FTIR, thermal analysis and zeta potential measurements and evaluated for drug loading capacity in adsorption batch experiments using diclofenac sodium (DS) as a model drug. In vitro drug release studies were performed in phosphate buffer pH 6.8 from comprimates containing: the drug adsorbed onto the selected modified diatomite sample (DAMD), physical mixture of the drug with the selected modified diatomite sample (PMDMD) and physical mixture of the drug with the starting diatomite (PMDD). In vivo acute toxicity testing of the modified diatomite samples was performed on mice. High adsorbent loading of the selected modified diatomite sample (similar to 250 mg/g in 2 h) enabled the preparation of comprimates containing adsorbed DS in the amount near to its therapeutic dose. Drug release studies demonstrated prolonged release of DS over a period of 8 h from both DAMD comprimates (18% after 8 h) and PMDMD comprimates (45% after 8 h). The release kinetics for DAMD and PMDMD comprimates fitted well with Korsmeyer-Peppas and Bhaskar models, indicating that the release mechanism was a combination of non-Fickian diffusion and ion exchange process.
PB  - Elsevier
T2  - Materials Science & Engineering C-Materials For Biological Applications
T1  - Inorganically modified diatomite as a potential prolonged-release drug carrier
VL  - 42
SP  - 412
EP  - 420
DO  - 10.1016/j.msec.2014.05.052
ER  - 
@article{
author = "Janicijevic, Jelena and Krajisnik, Danina and Calija, Bojan and Dobricic, Vladimir and Dakovic, Aleksandra and Krstić, Jugoslav and Marković, Marija and Milic, Jela",
year = "2014",
abstract = "Inorganic modification of diatomite was performed with the precipitation product of partially neutralized aluminum sulfate solution at three different mass ratios. The starting and the modified diatomites were characterized by SEM-EDS, FTIR, thermal analysis and zeta potential measurements and evaluated for drug loading capacity in adsorption batch experiments using diclofenac sodium (DS) as a model drug. In vitro drug release studies were performed in phosphate buffer pH 6.8 from comprimates containing: the drug adsorbed onto the selected modified diatomite sample (DAMD), physical mixture of the drug with the selected modified diatomite sample (PMDMD) and physical mixture of the drug with the starting diatomite (PMDD). In vivo acute toxicity testing of the modified diatomite samples was performed on mice. High adsorbent loading of the selected modified diatomite sample (similar to 250 mg/g in 2 h) enabled the preparation of comprimates containing adsorbed DS in the amount near to its therapeutic dose. Drug release studies demonstrated prolonged release of DS over a period of 8 h from both DAMD comprimates (18% after 8 h) and PMDMD comprimates (45% after 8 h). The release kinetics for DAMD and PMDMD comprimates fitted well with Korsmeyer-Peppas and Bhaskar models, indicating that the release mechanism was a combination of non-Fickian diffusion and ion exchange process.",
publisher = "Elsevier",
journal = "Materials Science & Engineering C-Materials For Biological Applications",
title = "Inorganically modified diatomite as a potential prolonged-release drug carrier",
volume = "42",
pages = "412-420",
doi = "10.1016/j.msec.2014.05.052"
}
Janicijevic, J., Krajisnik, D., Calija, B., Dobricic, V., Dakovic, A., Krstić, J., Marković, M.,& Milic, J.. (2014). Inorganically modified diatomite as a potential prolonged-release drug carrier. in Materials Science & Engineering C-Materials For Biological Applications
Elsevier., 42, 412-420.
https://doi.org/10.1016/j.msec.2014.05.052
Janicijevic J, Krajisnik D, Calija B, Dobricic V, Dakovic A, Krstić J, Marković M, Milic J. Inorganically modified diatomite as a potential prolonged-release drug carrier. in Materials Science & Engineering C-Materials For Biological Applications. 2014;42:412-420.
doi:10.1016/j.msec.2014.05.052 .
Janicijevic, Jelena, Krajisnik, Danina, Calija, Bojan, Dobricic, Vladimir, Dakovic, Aleksandra, Krstić, Jugoslav, Marković, Marija, Milic, Jela, "Inorganically modified diatomite as a potential prolonged-release drug carrier" in Materials Science & Engineering C-Materials For Biological Applications, 42 (2014):412-420,
https://doi.org/10.1016/j.msec.2014.05.052 . .

DSpace software copyright © 2002-2015  DuraSpace
About CeR – Central Repository | Send Feedback

re3dataOpenAIRERCUB
 

 

All of DSpaceInstitutions/communitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About CeR – Central Repository | Send Feedback

re3dataOpenAIRERCUB